James M. Johnston, MD
Dr. Johnston's practice includes all aspects of patient care related to neurological surgery, including neurosurgical oncology (brain and spine tumors), complex spinal surgery, craniosynostosis, vascular neurosurgery (including revascularization for moyamoya), radiosurgery, neurocritical care and tr
Since 1911, Children’s of Alabama has provided specialized medical care for ill and injured children. Ranked among the best pediatric medical centers in the nation by U.S. News & World Report, Children’s provided care for youngsters from every county in Alabama and 42 other states, representing more than 684,000 outpatient visits and more than 15,000 inpatient admissions. With more than 3.5 million square feet, it is one of the largest pediatric medical facilities in the United States. Children’s offers inpatient and outpatient services across its Russell Campus on Birmingham’s historic Southside with additional specialty services provided at Children’s South, Children’s on 3rd and in Huntsville and Montgomery. Primary care is provided at more than a dozen medical offices in communities across central Alabama. Children’s of Alabama is the only medical center in Alabama dedicated solely to the care and treatment of children. It is a private, not-for-profit medical center that serves as the teaching hospital for the University of Alabama at Birmingham (UAB) pediatric medicine, surgery, psychiatry, research and residency programs. The medical staff consists of UAB faculty and Children’s of Alabama’s full-time physicians as well as private practicing community physicians.
Justin McCroskey | Clinical Research Coordinatorhttps://www.childrensal.org/
Justin McCroskey, MS, MBA
Justin McCroskey is a Clinical Research Coordinator II at the University of Alabama at Birmingham and Children’s of Alabama. He received his Bachelor’s degree and Master’s degree in Exercise Science from Auburn University as well as a Master’s of Business Administration from the University of Alabam
Erwin G. Van Meir, PhD
Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic molecules and is currently developing novel small molecule inhibitors of the hypoxia-inducible factor pathway. His research aims to translate these novel agents to testing in clinical tri